CXCL8 and rheumatoid arthritis: Fechtner et al. found that EGCG, EGC, and EC differentially interfere with the IL1β signaling pathway which regulates the expression of pro-inflammatory mediators (IL6 and IL8) and COX2 in primary human rheumatoid arthritis synovial fibroblasts.